Recurrent Glioblastoma

• UAB Comprehensive Cancer Center — Birmingham, Alabama, United States
• Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
• Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States

• Northwestern University — Chicago, Illinois, United States

• M D Anderson Cancer Center — Houston, Texas, United States

• Center for Neurosciences — Tucson, Arizona, United States
• City of Hope — Duarte, California, United States
• University of California, San Francisco (UCSF) — San Francisco, California, United States
• University of Colorado Cancer Center — Aurora, Colorado, United States

• Beaumont Hospital — Royal Oak, Michigan, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• John Theurer Cancer Center — Hackensack, New Jersey, United States
• Lenox Hill Hospital — New York, United States

• Stanford University, School of Medicine — Palo Alto, California, United States

• Massachusetts General Hospital — Boston, Massachusetts, United States

• Dr. Senckenberg Institute of Neurooncology — Frankfurt, Germany
• University of Tuebingen — Tübingen, Germany

Not specified

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bethesda, Maryland, United States